Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05623020 |
|---|---|
| Brief Title: | A Study to Learn About the Effects of the Combination of Elranatamab (PF-06863135), Daratumumab, and Lenalidomide Compared With Daratumumab, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant (MagnetisMM-6) |
| First Submitted : | October 26, 2022 |
| First Submitted that Met QC Criteria : | November 11, 2022 |
| First Posted : | November 21, 2022 |
| Last Update Submitted that Met QC Criteria : | April 15, 2024 |
| Last Update Posted : | April 16, 2024 |